There is no such thing as 'diversity'!

Current Opinion in Chemical Biology

Volumn 9, Issue 3, 2005, Pages 293-295

  Roth, Hans Jörg ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAY; CHEMICAL STRUCTURE; COMBINATORIAL CHEMISTRY; SHORT SURVEY;

EID: 20444407684     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2005.03.002     Document Type: Article

References (10)

1. Y. Martin, J. Kofron, and L. Traphagen Do structurally similar molecules have similar biological activity ? J Med Chem 45 2002 4350 4358
2. R. Taylor Simulation analysis of experimental design strategies for screening random compounds as potential new drugs and agrochemicals J Chem Inf Comput Sci 35 1995 59 67
3. S. Delaney Assessing the ability of chemical similarity measures to discriminate between active and inactive compounds Mol Diversity 1 1996 217 222
4. H. Kubinyi Similarity and dissimilarity - a medicinal chemist's view Perspect Drug Discovery Des 11 1998 225 252
5. D. Gorse, and R. Lahana Funtional diversity of compound libraries Curr Opin Chem Biol 4 2000 287 294
6. Y. Martin Molecular diversity: how we measure it? Has it lived up to its promise? Il farmaco 56 2001 137 139
7. Martin Y, Brown R, Bures M: Quantifying diversity. In Combinatorial Chemistry and Molecular Diversity in Drug Discovery. Wiley:1998; 369-385.
8. S. Young, and N. Ge Design of diversity and focused combinatorial libraries in drug discovery Curr Opin Drug Discov Dev 7 2004 318 324
9. S. Rose, and A. Stevens Computational design strategies for combinatorial libraries Curr Opin Chem Biol 7 2003 331 339
10. Y. Martin Diverse viewpoints on computational aspects of molecular diversity J Comb Chem 3 2001 231 250